Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 68Leukemia 56Myelodysplastic Syndromes 53Lymphoma 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Lymphoma, Non-Hodgkin 43Multiple Myeloma 40Hodgkin Disease 39Leukemia, Lymphocytic, Chronic, B-Cell 35Congenital Abnormalities 30Lymphoma, Follicular 28Lymphoma, Large B-Cell, Diffuse 27Lymphoma, Mantle-Cell 26Neoplasms, Plasma Cell 25Lymphoma, B-Cell, Marginal Zone 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Burkitt Lymphoma 23Myeloproliferative Disorders 22Lymphoma, Large-Cell, Immunoblastic 22Leukemia, Myelomonocytic, Chronic 22Blast Crisis 22Leukemia, Myeloid, Chronic-Phase 21Leukemia, Myeloid, Accelerated Phase 21Primary Myelofibrosis 19Lymphoma, T-Cell, Cutaneous 15Hematologic Neoplasms 15Graft vs Host Disease 15Dendritic Cell Sarcoma, Interdigitating 14Anemia, Refractory, with Excess of Blasts 14Waldenstrom Macroglobulinemia 13

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Clofarabine 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Metabolic Diseases × Busulfan × Clear all
NCT01596699 2020-02-26

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

University of California, San Francisco

Phase 2 Terminated
16 enrolled 11 charts

Bone Marrow Failure Disorders, Metabolic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡